NICEVIVA
DRUG INTERACTION RECORDED 1 Prescription Drug Interaction(s) Reported — Review the pharmacokinetic interaction matrix below before use.
Pharmacokinetic Alert
MONOGRAPH SPEC LATEST 2026

Magnesium (Stress)

STRESS MOOD · Evidence Monograph

Magnesium (Stress) is an evidence-graded stress mood monograph evaluated across 30 peer-reviewed PubMed studies (2 meta-analyses, 6 systematic reviews, and 5 randomized controlled trials, encompassing n = 20,789 cumulative participants). Current clinical evidence is rated GRADE High (4.0 / 4.0) for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

Evidence Grade (GRADE) High (4.0 / 4.0)
Indexed PubMed Studies 30 Studies
Meta-Analyses · Reviews 2 Meta · 6 Systematic Reviews
Randomized Trials (RCT) 5 RCTs (2 Double-Blind)
Cumulative Participants n = 20,789
Reported Trial Dosages 300 mg · 90 mg/day · 30 mg/day
Trial Duration Range 7 days · 9 days · 6 weeks
Reading Time ~15 min
RECOMMENDED FOR Clinical Indication

Evidence Supports Supplementation When:

  1. 01 Individuals seeking evidence-backed support for targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support (supported by 30 indexed PubMed studies, GRADE High).
  2. 02 Adults matching clinical trial dosing protocols (300 mg · 90 mg/day · 30 mg/day) over a structured 7 days evaluation window.
  3. 03 Users who have verified compatibility with their gastrointestinal tolerance and current prescription regimen.
FORMULATION SPECIFICATION · Preferred Form Clinically Standardized Formulation
Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.
CLINICAL RESPONSE · Body Signal Check
Expected Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.
Dose Adjustment Signal: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.
CHRONOBIOLOGY · Optimal Dosing Window PM 12:30
Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.
Primary Clinical Endpoints & Physiological Biomarkers Studied Based on Indexed PubMed Trials
Primary stress mood clinical efficacy (30 PubMed studies)
Quantitative biomarker & outcome analysis (10 studies with effect-size/sample data)
Randomized controlled trial verification (5 RCTs · 2 double-blind)
Systematic review & meta-analysis synthesis (2 meta-analyses · 6 reviews)
01

What Is Magnesium (Stress) & Why Does Form Matter?

Magnesium (Stress) is classified under STRESS MOOD and has been investigated across 30 peer-reviewed PubMed publications for its role in targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support.

In clinical nutrition, physiological efficacy depends heavily on the specific chemical salt, chelate, or standardized extract used, as well as adherence to trial-validated dosing (300 mg, 90 mg/day, 30 mg/day).

02

Who Benefits Most & Common Depletion Factors

Suboptimal status or increased physiological demand for Magnesium (Stress) frequently arises from restrictive dietary patterns, age-related declines in gastrointestinal absorption, chronic metabolic stress, or medication-induced nutrient depletion.

Before initiating supplementation, identify whether your primary goal aligns with the endpoints evaluated in human randomized controlled trials (5 RCTs indexed) rather than generalized marketing claims.

03

Physiological Mechanism of Action

Within human physiology, Magnesium (Stress) acts on pathways governing targeted physiological homeostasis, clinical biomarker modulation, and evidence-based nutritional support. Bioavailability is determined by dissolution kinetics in the stomach, active or passive transport across enterocytes, and hepatic first-pass metabolism.

Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

04

PubMed Clinical Evidence & GRADE Evaluation

NICEVIVA assigns Magnesium (Stress) an overall evidence rating of GRADE High (4.0 / 4.0) based on 30 PubMed studies: 2 meta-analyses, 6 systematic reviews, and 5 randomized controlled trials (2 double-blind, n = 20,789 total participants).

Representative peer-reviewed findings include: • PMID:42075548 (2026) — "Rosacea and Hippophae rhamnoides: A Phytonutrient Approach to Skin Repair (The Systematic Review)." (Conclusions: Hippophae rhamnoides shows promising anti-inflammatory and skin-repairing effects that may benefit patients with rosacea.) • PMID:42075070 (2026) — "Age-Related Differences in Oral Microbiota Among Obese Patients with Periodontitis: A Systematic Review." (Conclusions: Age likely modifies the obesity-periodontitis-microbiota axis, but direct comparative evidence on adults remains limited.) • PMID:42074033 (2026) — "The Prognostic Value of Pre-Procedural and Post-Procedural Inflammatory-Oxidative Stress Biomarkers in Acute Coronary Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis." (In conclusion, inflammatory and oxidative stress biomarkers, particularly sST2 and GDF-15, demonstrate consistent associations with adverse outcomes in ACS patients undergoing PCI, offering more reliable baseline risk stratification than post-procedural measurements.)

05

Formulation Selection, Dosing & Chronobiology

Recommended Formulation: Clinically Standardized Formulation. Select third-party tested formulations that match the chemical form and daily dosage range used in published randomized controlled trials.

Clinical Trial Dosing & Timing: Published studies most commonly utilize 300 mg · 90 mg/day · 30 mg/day · 210 mg over 7 days · 9 days · 6 weeks · 8 days. Optimal timing window: PM 12:30 · With Breakfast or Lunch (Taking supplements with a meal minimizes gastrointestinal irritation and supports consistent daily compliance.).

06

Body Response Monitoring & Dose Adjustment

Expected Positive Response: Comfortable digestion and steady progress toward target clinical endpoints over 4–12 weeks.

Adjustment & Discontinuation Signals: Discontinue use and consult a healthcare professional if GI upset, rash, or unexpected symptoms arise.

07

Prescription Drug Interactions & Contraindications

• [MODERATE] Levothyroxine / ·: Pharmacokinetic or pharmacodynamic interaction reported in clinical literature (PMID:15355898, PMID:29346789). Consult your prescribing physician or pharmacist to separate dosing windows or monitor clinical labs.

08

4 Essential Safety Rules Before & After Dosing

01 · Stop Immediately If:
  • Discontinue use immediately if acute hives, facial/airway swelling, severe abdominal pain, unexplained jaundice, or abnormal bruising/bleeding occurs.
  • Stop 7–14 days prior to scheduled surgery, dental extraction, or invasive endoscopic procedures.
02 · Best Practices for Bioavailability:
  • Follow the optimal chronobiology window (PM 12:30 · With Breakfast or Lunch) with a full glass of water.
  • Stay within clinically studied daily dosages (300 mg · 90 mg/day · 30 mg/day) and re-evaluate efficacy after 7 days.
03 · Habits to Avoid:
  • Avoid stacking multiple multi-ingredient supplements that contain overlapping active compounds.
  • Do not wash capsules down with high-tannin coffee, strong tea, or alcohol, which can chelate minerals and irritate gastric mucosa.
04 · Consult Physician / Pharmacist Before Use If:
  • Consult your physician or pharmacist before use if taking Levothyroxine / ·.
  • Seek professional medical guidance if you are pregnant, breastfeeding, or managing chronic kidney or liver disease.
09 · PUBMED CLINICAL STUDIES

Indexed PubMed Clinical Studies & Abstracts (30 Studies) · 10 Quantitative Analyses

01
SYSTEMATIC REVIEW Medicina (Kaunas, Lithuania) (2026) PMID: 42075548 ↗
Rosacea and Hippophae rhamnoides: A Phytonutrient Approach to Skin Repair (The Systematic Review).
Clinical Trial Synthesis 2026 Systematic Review published in Medicina (Kaunas, Lithuania). Key conclusion: Conclusions: Hippophae rhamnoides shows promising anti-inflammatory and skin-repairing effects that may benefit patients with rosacea.
View Original PubMed Abstract ↓

Background and Objectives: Rosacea is a chronic inflammatory dermatosis with a complex pathophysiology that continues to challenge effective long-term disease management. Rosacea is characterized by immune dysregulation, oxidative stress, neurovascular dysfunction, and impaired epidermal barrier integrity, while current therapeutic options remain limited. Hippophae rhamnoides (sea buckthorn) is a phytochemically rich medicinal plant with reported anti-inflammatory and dermo-reparative properties. Materials and Methods: A systematic literature review was conducted following PRISMA guidelines using the PubMed database. Studies published from 2020 onward evaluating sea buckthorn extracts, oils, or isolate bioactive compounds in the in vitro, in vivo, and limited clinical contexts were included, with emphasis on rosacea relevant mechanisms. Results: Twenty-six studies show that sea buckthorn compounds modulate inflammation, oxidative stress, vascular and immune responses, and barrier function in preclinical models. They consistently reduce pro-inflammatory mediators, improve barrier integrity, and attenuate immune or vascular activation, suggesting potential benefits for inflammatory skin disorders such as rosacea. Conclusions: Hippophae rhamnoides shows promising anti-inflammatory and skin-repairing effects that may benefit patients with rosacea. However, most evidence comes from preclinical studies, and clinical data specifically for rosacea are limited. Well-designed clinical trials are needed to confirm its effectiveness in treating this condition.

02
SYSTEMATIC REVIEW Nutrients (2026) PMID: 42075070 ↗
Age-Related Differences in Oral Microbiota Among Obese Patients with Periodontitis: A Systematic Review.
Clinical Trial Synthesis 2026 Systematic Review published in Nutrients. Key conclusion: Conclusions: Age likely modifies the obesity-periodontitis-microbiota axis, but direct comparative evidence on adults remains limited.
View Original PubMed Abstract ↓

Background: Obesity and periodontitis are linked through inflammatory and metabolic pathways, and the oral microbiota may mediate this interaction. Age-related changes in immunity, salivary function, and cumulative exposure may modify obesity-associated periodontal dysbiosis. Objective: We sought to synthesize the potential for age-related differences in the oral microbiota of adult obese patients with periodontitis and assess the strength of current literature in supporting age-specific interpretations. Methods: A systematic search of PubMed/MEDLINE, Scopus, and Embase identified 1088 records. After screening and full-text assessment, 50 studies that met the criteria for focused qualitative synthesis remained. Within that review corpus, 10 representative adult human studies provided the most direct evidence linking obesity or overweight, periodontal phenotype, oral microbiota, and age-relevant interpretation. Risk of bias was appraised with the Newcastle-Ottawa Scale. Results: Direct head-to-head microbiome comparisons between younger and older obese adults with periodontitis are rare. Direct evidence links obesity to greater periodontal inflammatory burden, enrichment of classical periopathogens and bridging taxa, and shifts in community structure. Contextual aging studies have suggested that older adults may more often harbor lower-diversity, persistence-oriented communities enriched in stress-tolerant, proteolytic, or opportunistic taxa, whereas younger obese adults more often show inflammation-amplifying consortia enriched in classical periopathogens and bridging taxa. However, these patterns remain largely hypothesis-generating because the evidence base is heterogeneous and predominantly cross-sectional. Conclusions: Age likely modifies the obesity-periodontitis-microbiota axis, but direct comparative evidence on adults remains limited. The current literature supports cautious age-aware interpretation within a systematic review framework rather than definitive age-specific microbial signatures or treatment algorithms.

03
META-ANALYSIS International journal of molecular sciences (2026) PMID: 42074033 ↗
The Prognostic Value of Pre-Procedural and Post-Procedural Inflammatory-Oxidative Stress Biomarkers in Acute Coronary Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Clinical Trial Synthesis 2026 Meta-Analysis published in International journal of molecular sciences involving n = 18,933 participants; statistical significance reported at p = 0.0001 (HR 3.32). Key conclusion: In conclusion, inflammatory and oxidative stress biomarkers, particularly sST2 and GDF-15, demonstrate consistent associations with adverse outcomes in ACS patients undergoing PCI, offering more reliable baseline risk stratification than post-procedural measurements.
View Original PubMed Abstract ↓

Acute coronary syndrome patients undergoing percutaneous coronary intervention remain at high risk for major adverse cardiovascular events (MACE: cardiovascular mortality, non-fatal myocardial infarction, and stroke). Inflammatory-oxidative stress biomarkers are potential prognostic tools; however, the influence of sampling timing-pre-procedural versus post-procedural-remains unclear. This meta-analysis evaluated six biomarkers: sST2, GDF-15, OPG, sLOX-1, H-FABP, and Galectin-3. Pooled Hazard Ratios (HRs) for time-to-event outcomes and Standardized Mean Differences (SMDs) between event and non-event groups were synthesized using random-effects models involving 40 studies (18,933 patients). Elevated pre-procedural levels of sST2 (HR = 3.32, p < 0.0001), GDF-15 (HR = 3.00, p < 0.0001), sLOX-1 (HR = 2.61, p = 0.0023), and OPG (HR = 1.79, p = 0.0206) significantly predicted MACE. Notably, pre-PCI sST2 strongly predicted heart failure hospitalization (HR = 6.30, p < 0.0001). Additionally, pre-PCI H-FABP demonstrated a moderate significant effect on adverse outcomes (SMD = 0.67, p < 0.0001). While pre-PCI Galectin-3 was not significant, its post-procedural levels showed a large significant effect (SMD = 1.15, p < 0.0001). In conclusion, inflammatory and oxidative stress biomarkers, particularly sST2 and GDF-15, demonstrate consistent associations with adverse outcomes in ACS patients undergoing PCI, offering more reliable baseline risk stratification than post-procedural measurements.

04
SYSTEMATIC REVIEW Early intervention in psychiatry (2026) PMID: 42070903 ↗
Unravelling Distress in Psychotic-Like Experiences: A Systematic Review of Non-Clinical Populations.
Clinical Trial Synthesis 2026 Systematic Review published in Early intervention in psychiatry. Key conclusion: Future research should harmonise definitions of distress, examine longitudinal pathways and evaluate resilience-building approaches to mitigate risk and improve mental he
View Original PubMed Abstract ↓

INTRODUCTION: Psychotic-like experiences (PLEs) are subthreshold psychotic phenomena that occur along the psychosis continuum and are frequently accompanied by distress. However, the factors underlying distress in individuals reporting PLEs-particularly within non-clinical populations-remain insufficiently understood. This systematic review aims to synthesise the evidence on factors directly or indirectly associated with distress in PLEs among non-clinical samples. METHODS: A systematic search of Medline, Web of Science, Embase, and Cochrane (January 2000-March 2025) using the terms psychotic-like experiences AND (distress OR resilience OR burden OR coping OR adaptive behaviour) identified 762 studies, of which 111 met inclusion criteria and were included in a narrative synthesis. RESULTS: Distress related to PLEs can be differentiated into direct PLE-related distress and indirect psychological distress. Factors associated with distress clustered into three domains: (i) Symptomatology-greater frequency, intensity, persistence and specific subtypes predict higher distress, as do comorbid depression, anxiety and suicidality. (ii) Psychological factors-maladaptive metacognitive biases, poor emotion regulation and avoidant or emotion-focused coping contribute to distress, whereas self-compassion and problem-focused coping may be protective. (iii) Environmental and contextual factors-traumatic life events, discrimination, daily stressors and substance use amplify distress, often by interacting with internal vulnerabilities and emotion regulation capacities. CONCLUSION: Distress in PLEs arises from the interaction between symptom features, internal psychological vulnerabilities and external environmental factors. Consistent with emotion regulation models, distress reflects disruptions in adaptive appraisal and coping processes that heighten emotional reactivity. Conceptualizing distress as a transdiagnostic vulnerability underscores its relevance for early identification and preventive interventions. Future research should harmonise definitions of distress, examine longitudinal pathways and evaluate resilience-building approaches to mitigate risk and improve mental he

05
SYSTEMATIC REVIEW The journal of sexual medicine (2026) PMID: 42070118 ↗
Masturbation as a sexual and psychological coping strategy in long-distance relationships: a systematic review.
Clinical Trial Synthesis 2026 Systematic Review published in The journal of sexual medicine. Key conclusion: Psychologically, it served as a coping strategy for sleep and stress, but excessive engagement increased anxiety and reduced emotional well-being.
View Original PubMed Abstract ↓

INTRODUCTION: Long-distance relationships (LDRs) reduce opportunities for physical intimacy, often prompting individuals to seek alternative sexual activities such as masturbation. Although common, its influence on sexual satisfaction, sexual health, psychological well-being, and relational stability in LDRs remains understudied. Moreover, cultural and population differences shape diverse meanings and perspectives on masturbation. OBJECTIVES: We employed a systematic review approach to explore the role of masturbation within long-distance relationships. Specifically, this review aims to examine how masturbation is associated with sexual, relational, and psychological outcomes and how these perspectives vary across cultural contexts. METHODS: A systematic review was conducted following the PRISMA guidelines, compiling both quantitative and qualitative studies on masturbation as an alternative sexual activity in LDRs as well as its implications for sexual satisfaction, relationship satisfaction, and psychological well-being. RESULTS: Fourteen studies were eligible for further analysis in which men reported higher frequencies of masturbation compared to women, with significant increases observed in the context of long-distance relationships and during COVID-19 quarantine periods. Men were mainly motivated by biological release, orgasm, and stress reduction, often with pornography, whereas women reported broader motives such as relaxation, better sleep, stress relief, and emotional closeness. The effects on sexual satisfaction were mixed: masturbation was reported to be associated with greater body awareness, self-esteem, and relational harmony, yet excessive frequency was linked to lower satisfaction and arousal. Mutual, technology-mediated practices helped maintain intimacy, while excessive solitary use undermined relationship quality. From a sexual health perspective, moderate masturbation may be associated with indirect benefits through improved body awareness, whereas frequent use was linked to poorer experiences. Psychologically, it served as a coping strategy for sleep and stress, but excessive engagement increased anxiety and reduced emotional well-being. CO

06
CLINICAL STUDY Frontiers in plant science (2026) PMID: 42064305 ↗
Precise scheduling of B-box transcription factors: the core network for balancing plant growth, metabolism and stress resistance.
Clinical Trial Synthesis 2026 Clinical Study published in Frontiers in plant science. Key conclusion: Analyzing these crucial regulatory networks will establish a fundamental framework and molecular targets for precisely manipulating the core domains or interaction interfaces of BBX proteins, thereby improving crop quality and resilience through approaches like gene editing, thus
View Original PubMed Abstract ↓

The B-box (BBX) zinc finger transcription factor family functions as a central regulatory hub in plants, responsible for perceiving and integrating environmental signals to coordinate growth, development, and stress adaptation. Typically, members of this family typically contain one or two conserved B-box domains, with certain members also containing CCT domains or VP motifs, these multi-domain architectures underlie the functional diversity of BBX proteins. This review summarizes the key roles of BBX proteins across the plant life cycle-including growth regulation, secondary metabolism, photomorphogenesis, and responses to biotic and abiotic stresses. Given the distinct regulatory capacity of BBX proteins in harmonizing environmental signals with crucial agronomic traits in horticultural crops, such as stress resilience and secondary metabolite production, further investigation is needed to decipher functional redundancy and interaction networks among BBX members, elucidate their integrated response mechanisms under complex field conditions. Analyzing these crucial regulatory networks will establish a fundamental framework and molecular targets for precisely manipulating the core domains or interaction interfaces of BBX proteins, thereby improving crop quality and resilience through approaches like gene editing, thus promoting their effectiveness in precision breeding.

07
META-ANALYSIS Frontiers in nutrition (2026) PMID: 42063954 ↗
The effect of exogenous ketone bodies on cognition across health and disease: a systematic review and meta-analysis.
Clinical Trial Synthesis 2026 Meta-Analysis published in Frontiers in nutrition involving n = 1,602 participants; statistical significance reported at p = 0.001 (SMD 0.29). Key conclusion: DISCUSSION: EK supplementation is associated with modest improvements in cognitive performance across diverse populations and study designs.
View Original PubMed Abstract ↓

INTRODUCTION: Cognitive function is closely linked to brain energy metabolism and may be compromised by aging, metabolic stress, and neuropsychiatric disease. Ketone bodies can serve as an alternative cerebral fuel and may also exert signaling effects relevant to cognition. Exogenous ketones (EK) offer a practical means of increasing circulating ketone concentrations without dietary carbohydrate restriction. However, the overall effect of EK supplementation on cognitive performance in humans has not been systematically quantified. METHODS: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. PubMed, Web of Science, and Embase were searched through October 2025 for randomized controlled trials investigating the effects of EK on cognitive outcomes in healthy adults or individuals with neuropsychiatric conditions. Data extraction and quality assessment were performed independently by multiple reviewers using the PEDro scale. Standardized mean differences (SMD) were calculated using random-effects models. Subgroup and meta-regression analyses examined the influence of ketone formulation, intervention duration, dose, population type, and presence of acute cognitive stressors. RESULTS: 38 studies comprising 41 protocols (1,602 participants) were included in the systematic review, with 29 protocols (1,117 participants) eligible for meta-analysis. EK supplementation was associated with a statistically significant improvement in cognitive performance compared with placebo (SMD = 0.29, 95% CI 0.16-0.41; p < 0.001). Sub-group analyses did not show statistically significant differences between the type of supplementation (p = 0.083), study duration (acute vs. intermediate; p = 0.11), population type (healthy vs. Alzheimer's disease; p = 0.077), or the presence of acute cognitive stressors (p = 0.89). Meta-regression revealed a positive association between daily EK dose and cognitive improvement. DISCUSSION: EK supplementation is associated with modest improvements in cognitive performance across diverse populations and study designs. These findings support EK as a flexible nutritional strategy for cognitive support and warrant further i

08
SYSTEMATIC REVIEW Frontiers in nutrition (2026) PMID: 42063948 ↗
Nutritional and phytogenic modulation of caprine physiology: a systematic review of Moringa oleifera effects on metabolism, reproductive function, and lactation performance.
Clinical Trial Synthesis 2026 Systematic Review published in Frontiers in nutrition. Key conclusion: The benefits of lactational responses were improved milk output and production of milk fat and protein, in addition to a more desirable composition of fatty acids and enhanced oxidative stability of milk.
View Original PubMed Abstract ↓

INTRODUCTION: Moringa oleifera (M. oleifera) is highlighted as a diverse-purpose feed in the nutrition of small ruminants. This is a systematic review that compared its effects on goats based on a predetermined PICO model (Population: goats in different physiological phases; Intervention: dietary M. oleifera in the forms of leaf meal, extract, or silage; Comparison: no interventions; Outcomes: growth performance, antioxidant status, reproduction, and milk yield and quality). METHODS: The PRISMA guidelines were used to identify the studies from the search included PubMed, Scopus, Web of Science, ScienceDirect, and Google Scholar, and the publication window was January 2015 to December 2025 and screened them with systematic eligibility criteria to minimize selection bias. RESULTS AND DISCUSSION: Regular addition of moderate amounts of Moringa supplements had a consistent beneficial effect on nutrient utilization and growth efficiency, and on nitrogen balance, with fibre digestibility improving by around 25%. An intensive antioxidant response was observed, as evidenced by significant increases in enzymatic defenses (e.g., superoxide dismutase upsurge by more than 100% at certain phases) and dramatic decreases in lipid peroxidation (malondialdehyde drops by approximately 70%). Reproductive performance was positively affected by an improvement in endocrine functionality, and progesterone levels during early pregnancy rose up to ~90%." in supplemented doses, and litter size and offspring viability improved. The benefits of lactational responses were improved milk output and production of milk fat and protein, in addition to a more desirable composition of fatty acids and enhanced oxidative stability of milk. The evidence is that M. oleifera is a highly nutritional phytogenic nutraceutical capable of enhancing metabolic efficiency, oxidative balance, reproductive performance, and quality of milk in goats. It produces benefits at moderate dietary inclusion levels, with physiological optimization as opposed to maximal dosing.

09
SYSTEMATIC REVIEW BMC psychology (2026) PMID: 42063172 ↗
Neurological and biological correlations of ODD with ADHD in children and adolescents: a systematic review.
Clinical Trial Synthesis 2026 Systematic Review published in BMC psychology. Key conclusion: CONCLUSION: ODD along with ADHD showed a distinct neurobiological and physiological pattern from ADHD alone.
View Original PubMed Abstract ↓

BACKGROUND: Attention Deficit Hyperactivity Disorder (ADHD) often coexists with Oppositional Defiant Disorder (ODD), exacerbating impairment. The distinct neurological and biological patterns that differentiate this comorbidity from ADHD alone remain unclear. METHOD: We conducted systematic review of multi model correlates differentiating ODD+ADHD from ADHD alone following PRISMA 2020 with databases like MEDLINE, EMBASE, CINAHL, PsycINFO and Web of Sciences until August 2025. 144 full texts were reviewed and 26 studies were selected for final inclusion after 1457 records with 37 other sources. Designs included cross-sectional case-control studies, longitudinal studies, and imaging based on the ABCD framework, while measures covered structural and functional MRI, diffusion MRI, resting and task fNIRS, EEG and ERP, HPA-axis and immune-metabolic biomarkers, and executive and cognitive indices. The evaluation of bias employed RoB 2, ROBINS-I, and JBI, while synthesis utilised Braun-Clarke thematic analysis. RESULTS: Oppositionality involved limbic-striatal and cerebello-cortical differences, with ODD+ADHD showing greater executive and emotion-processing deficits than ADHD alone. ODD was linked to lower cortisol and reduced sympathetic reactivity, while ADHD showed higher cortisol and tryptophan-kynurenine shifts, with cytokines decreasing after methylphenidate. CONCLUSION: ODD along with ADHD showed a distinct neurobiological and physiological pattern from ADHD alone. Such pattern is marked by greater executive and emotional regulation deficits with unique stress-response patterns, highlighting the need for tailored assessments and intervention approaches. © 2026. The Author(s).

10
CLINICAL STUDY Journal of medical Internet research (2026) PMID: 42060539 ↗
Digital Health Interventions for Family Members of ICU Patients: Current Evidence and Future Directions.
Clinical Trial Synthesis 2026 Meta-Analysis published in Journal of medical Internet research. Key conclusion: Rather than concluding that digital approaches are inherently ineffective, we argue that these null findings reflect identifiable and remediable limitations in intervention design, outcome measurement, and trial methodology.
View Original PubMed Abstract ↓

Comment on doi: 10.2196/83294. A recent systematic review and meta-analysis of randomized trials evaluating digital health interventions for family members of intensive care unit (ICU) patients found no significant improvements in anxiety, depression, posttraumatic stress, quality of life, or communication quality. Rather than concluding that digital approaches are inherently ineffective, we argue that these null findings reflect identifiable and remediable limitations in intervention design, outcome measurement, and trial methodology. In this commentary, we examine four structural barriers that currently constrain the evidence base and outline the conditions that next-generation trials must meet to adequately address the questions raised by this review. © Tanya Abenaim, Dan Poenaru, Michael Goldfarb. Originally published in the Journal of Medical Internet Research (https://www.jmir.org).

RELATED MONOGRAPHS

Related Monographs in This Category